Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Drug for treatment and postoperative care of uterus myoma

A technology for uterine fibroids and drugs, which is applied in the directions of anti-tumor drugs, drug combinations, and pharmaceutical formulations to achieve good curative effects and a wide range of applications.

Inactive Publication Date: 2013-08-14
潘玉梅
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Ultrasound therapy and radiation therapy have a strict scope of application, and there are certain risks. Generally, patients under the age of 40 should avoid using them

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0047] The raw material composition and the weight of active ingredient of medicine of the present invention are:

[0048] Atractylodes macrocephala 80g Angelica 70g Codonopsis 65g Stir-fried mustard ears 60g

[0049] Danpi 52g, Guizhi 48g, Paeoniae Alba 43g, Motherwort 38g

[0050] Chuanxiong 34g, peach kernel 30g, triangular 26g, raw rhubarb 23g

[0051] Curcuma 18g, Scutellaria baicalensis 14g, Poria cocos 10g, Sichuan Achyranthes bidentata 8g.

[0052] The processing steps of the pharmaceutical preparation method of the present invention are:

[0053] (1) Grind fried mustard ears, chuanxiong, and peach kernels into powder, pass through 120 mesh fine powder, and set aside.

[0054] (2) Steam the raw rhubarb thoroughly, grind it into powder, pass through 120 mesh fine powder, and set aside.

[0055] (3) Mix the Scutellaria baicalensis with Jimo old wine, stir-fry it with a slow fire and grind it into powder, pass it into a fine powder of 120 mesh, and set aside.

[0056...

Embodiment 2

[0061] The raw material composition and the weight of active ingredient of medicine of the present invention are:

[0062] Atractylodes macrocephala 75g Angelica 65g Codonopsis 60g Stir-fried mustard ears 55g

[0063] Danpi 50g, Guizhi 44g, Paeoniae Alba 38g, Motherwort 35g

[0064] Chuanxiong 31g, peach kernel 28g, triangular 23g, raw rhubarb 19g

[0065] Curcuma 15g, Scutellaria baicalensis 10g, Poria cocos 8g, Sichuan Achyranthes bidentata 5g.

[0066] The process steps, usage and dosage of the medicine preparation method in this embodiment are the same as those in Example 1.

[0067] clinical information:

[0068] Through clinical verification, the drug of the present invention has a total effective rate of 68.24% for intramural fibroids, 71.32% for subserosal fibroids, and 62.85% for submucosal fibroids , the total effective rate for cervical fibroids is 82.14%, and the total effective rate for multiple uterine fibroids is 83.49%, which fully meets the effective rate ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a drug for treatment and postoperative care of uterus myoma, and belongs to the field of traditional Chinese medicines. The effective constituents of the drug comprise the following raw materials in parts by weight: 70-90 parts of white atractylodes rhizome, 60-80 parts of angelica, 55-75 parts of codonopsis pilosula, 50-70 parts of fried schizonepeta spike, 45-60 parts ofcortex moutan, 40-55 parts of cassia twig, 35-50 parts of white paeony root, 30-45 parts of herba leonuri, 25-43 parts of ligusticum wallichii, 22-40 parts of peach kernel, 18-35 parts of rhizoma sparganii, 15-30 parts of raw rhubarb, 12-25 parts of curcuma zedoary, 8-20 parts of scutellaria baicalensis, 5-16 parts of poria cocos and 3-12 parts of radix cyathulae. According to the invention, the raw materials are reasonably mixed, the raw materials capable of promoting blood circulation to remove blood stasis, resolving hard lump, warming, activating meridian and tonifying vital energy and spleen are selected for pathogenic factors such as cold congealing stasis, spleen deficiency and damp obstruction, dried blood accumulation, uterus stasis and the like; the effects of finding a disease source by visiting and treating both symptoms and root causes are achieved by regulating the whole-body function and activating the immune system of a patient; and the drug has a very good treatment effect for intramural myoma, subserous myoma, submucous myoma and cervix myoma through clinic verification.

Description

Technical field [0001] The invention relates to the field of traditional Chinese medicine, in particular to a medicine for treating uterine fibroids and postoperative care. Background technique [0002] Uterine fibroids, also known as uterine leiomyomas, are the most common benign tumors of female genitalia. Most of them have no obvious symptoms. It causes pain, and if treatment is delayed, it can lead to female infertility, miscarriage, frequent urination, dysuria and other hazards, which is a major killer of women's health. According to the location of fibroids, there are four common types of uterine fibroids: intramural fibroids, submucosal fibroids, subserosal fibroids and cervical fibroids. [0003] Uterine fibroids can cause pelvic congestion and infection. After the subserosal fibroid pedicle is twisted, intestinal adhesions will occur, which will be infected by intestinal bacteria, or free fibroids will be formed due to the twisting of the tumor pedicle. Uterine fi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/9066A61P15/00A61P35/00
Inventor 潘玉梅韩静
Owner 潘玉梅
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com